Pomdoctor Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| POM | 1345.HK | TWY.F | 6618.HK | 002727.SZ | 3034.T | |
|---|---|---|---|---|---|---|
| Market cap | 4.31M | 2.27B | 5.68B | 137.92B | 7.89B | 94.92B |
| P/E (TTM) | — | 16.3 | 35.1 | 19.9 | 20.4 | 9.9 |
| Forward P/E | — | — | — | 14.6 | 13.7 | 7.7 |
| Price/book | -0.1 | 1.9 | 2.4 | 1.9 | 1.0 | 1.6 |
| Dividend yield | — | 5.71% | 2.30% | — | 2.98% | 2.24% |
| 1-year change | −98.65% | −2.97% | −47.67% | −33.23% | +0.07% | +22.70% |
| Today | +4.73% | +0.51% | +6.92% | +7.94% | +0.52% | +4.55% |
The closest companies by business and industry (Pharmaceutical Retailers). Prices may be delayed up to 20 min.
Latest news
All POM news ›POMDOCTOR receives two Nasdaq listing deficiency notices
Pomdoctor received two Nasdaq deficiency letters after falling below key market value listing requirements. POMDOCTOR (POM) received two deficiency letters from Nasdaq on October 28, 2026, for failing to meet certain continued listing…
POMDOCTOR LIMITED Announces Receipt of Nasdaq Notifications Regarding Continued Listing Requirements
Nov 02, 2026, 16:05 ET If the Company does not regain compliance prior to the expiration of the applicable compliance period, the Company will receive written notification that its securities are subject to delisting. At that time, the…
POMDOCTOR LIMITED Soars On Volatile Low-Priced Breakout
POMDOCTOR LIMITED stocks have been trading down by -25.58 percent amid reports of a critical product safety recall. Key Takeaways POMDOCTOR LIMITED has exploded from sub-$1 to $3.01, showing classic low-float breakout behavior that…
POMDOCTOR faces Nasdaq delisting determination
SCWorx Announces New Agreement with Healthcare System Knox and Palantir Partner to Further Accelerate Delivery of Software through Largest Federal Cloud Plug Power Appoints Dr. Lee Sweetland as Global Engineering Industrialization Lead Eos…
POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq
Oct 19, 2026, 08:30 ET The termination was previously approved by the board of directors of Pomdoctor on September 3, 2026 and approved by the Company's shareholders on a non-binding advisory basis at the extraordinary general meeting of…
Convergence of AI, Wearable Technology, Remote Patient Monitoring and Real-World Healthcare: PomDoctor Ltd. (N A S D A Q: POM)
CorporateAds PRLog Convergence of AI, Wearable Technology, Remote Patient Monitoring and Real-World Healthcare: PomDoctor Ltd. (N A S D A Q: POM) - AI-powered analysis:
POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare
The Manila Times POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare GUANGZHOU, China, Oct. 12, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ:
POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination
GUANGZHOU, China, Oct. 10, 2026 /PRNewswire/ — POMDOCTOR LIMITED (“Pomdoctor” or the “Company”) (Nasdaq: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthcare capabilities, today…
Nasdaq to suspend trading in Pomdoctor securities following non-compliance
TradingView Nasdaq to suspend trading in Pomdoctor securities following non-compliance - The company added that it intends to request a hearing before the Nasdaq Hearings Panel to appeal the staff's determination and to pres
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net3
- prnewswire.com2
- tradingview.com2
- financialcontent.com1
- laotiantimes.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 14 articles, not a forecast.